Results 91 to 100 of about 40,327 (258)

Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases [PDF]

, 2015
Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) is an important differential diagnosis in patients presenting with cholestasis and PSC-like cholangiographic changes in endoscopic retrograde cholangiography (ERC).
Adler, Andreas, Eurich, Dennis, Faber, Wladimir, Leonhardt, Silke, Neuhaus, Peter, Schott, Eckart, Seehofer, Daniel, Veltzke-Schlieker, Wilfried   +7 more
core   +1 more source

Success of transition to adult care in patients with pediatric‐onset chronic liver disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Previous studies on chronic pediatric‐onset conditions have highlighted the risks of loss to follow‐up, disease progression, or therapeutic nonadherence during transition. However, very few studies have focused on liver diseases.
Sarah Mongbo, Valérie Canva, Sébastien Dharancy, Guillaume Lassailly, Alexandre Louvet, Philippe Mathurin, Nassima Ramdane, Frédéric Gottrand, Madeleine Aumar   +8 more
wiley   +1 more source

Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature

Diagnostic Pathology, 2012
Autoimmune sclerosing cholangitis is an overlap syndrome characterized by features of both autoimmune hepatitis and primary sclerosing cholangitis, the latter usually involving the large bile ducts.
Larsen Erling, Bayat Allan, Vyberg Mogens   +2 more
doaj   +1 more source

Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis [PDF]

, 1991
To assess whether or not liver transplantation and subsequent immunosuppression with cyclosporine and prednisone affect ulcerative colitis symptomatology, we surveyed by questionnaire all 23 surviving patients with pretransplant colonoscopy-documented ...
Belle, SH, Delemos, B, Gavaler, C, Gavaler, JS, Heyl, AE, Starzl, TE, Tarter, RE, Van Thiel, DH   +7 more
core   +1 more source

Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study

JPGN Reports, EarlyView.
Abstract Objectives The efficacy of cystic fibrosis transmembrane conductance regulator (CFTR)‐modulator therapies in preventing or ameliorating cystic fibrosis liver disease (CFLD) by correcting CFTR in cholangiocytes is not well‐documented. This study aimed to assess liver function during CFTR‐modulators.
Laura Giugliano, Elisabetta Augustoni, Antonio Pizzol, Anna Opramolla, Cristina Chiadò, Anna Zagaria, Irene Esposito, Giulia Roberto, Alice Ponte, Andrea Evangelista, Paola Quarello, Michele Pinon, Pier Luigi Calvo   +12 more
wiley   +1 more source

Drug therapy of primary biliary diseases: classical and modern strategies [PDF]

, 2013
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich, Schlichting, Julia
core  

Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis [PDF]

, 2011
Background/Aims: The chromosome 4q27 region harboring IL2 and IL21 is an established risk locus for ulcerative colitis (UC) and various other autoimmune diseases.
Albers HM, Barrett JC, Barrett JC, Bergquist A, Bergquist A, Bo X, Burkhard Göke, Chapman R, Chen B, Christian Rust, Daha NA, Fay MP, Festen EA, Gerald Ulrich Denk, Gershwin ME, Gershwin ME, Glas J, Glas J, Henckaerts L, Hinks A, Hirschfield GM, Johannes Stallhofer, Jürgen Glas, Kaplan MM, Karlsen TH, Laurence A, Li Y, Liu Y, Loftus, Loftus EV, Maiti AK, Malek TR, Marquez A, McGuire HM, Peluso I, Rüdiger Paul Laubender, Saarinen S, Sadlack B, Saich R, Saraiva M, Sawalha AH, Sgouroudis E, Stephan Brand, Thomas Pusl, Todd JA, van Heel DA, Weismuller TJ, Yamanouchi J, Yang L, Zheng SG, Zhernakova A, Zhernakova A   +51 more
core   +1 more source

Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review

Case Reports in Gastroenterology
Introduction: Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon. About 5% of ulcerative colitis patients also present with primary sclerosing cholangitis, a chronic inflammatory disease marked by cholestasis and
Naama Lang, Yana Davidov, Tomer Hoffman, Sivan Harnik, Abraham Rami Eliakim, Shomron Ben-Horin, Bella Ungar   +6 more
doaj   +1 more source

Primary sclerosing cholangitis

Autoimmunity Reviews, 2003
Primary sclerosing cholangitis (PSC) is a fibrosing disease of the intra- and extra-hepatic bile ducts, and is closely associated with inflammatory bowel disease. It is immune mediated, rather than being a classical autoimmune disease. A range of immune abnormalities have been demonstrated in PSC, in particular the findings of a range of autoantibodies,
Cullen, S, Chapman, R
openaire   +2 more sources

Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use

Gastro Hep Advances
Ketamine-induced sclerosing cholangitis has been described with chronic intranasal and intravenous use. Our case follows chronic topical use for peripheral neuropathy.
Gerond Lake-Bakaar, Benjamin Milgrom, Clark Kulig, Andrea K. Sotelo, Joselle Speirs, Alexandra Meihofer   +5 more
doaj   +1 more source